Safety and Tolerability of Moxonidine in the Treatment of Hypertension

ISSN： 0114-5916

Source： Drug Safety, Vol.19, Iss.3, 1998-09, pp. : 191-203

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety and Tolerability of the Antibacterial Rifaximin in the Treatment of Travellers' Diarrhoea

By Ericsson Charles D.

Drug Safety, Vol. 29, Iss. 3, 2006-01 ,pp. : 201-207

Adis International

Access to resources Recommend Favorite

Safety and Tolerability of Antiepileptic Drug Treatment in Children with Epilepsy

By Guerrini Renzo

Drug Safety, Vol. 35, Iss. 7, 2012-07 ,pp. : 519-533

Adis International

Access to resources Recommend Favorite

The safety and tolerability of botulinum toxins for the treatment of cervical dystonia

By Brashear Allison

Expert Opinion on Drug Safety, Vol. 4, Iss. 2, 2005-03 ,pp. : 241-249

Informa Healthcare

Access to resources Recommend Favorite

The safety of antihypertensives for treatment of pregnancy hypertension

By Magee LA Abdullah S

Expert Opinion on Drug Safety, Vol. 3, Iss. 1, 2004-01 ,pp. : 25-38

Informa Healthcare

Access to resources Recommend Favorite

Moxonidine and Ramipril in Patients with Hypertension and Obstructive Pulmonary Disease

By Feuring M.

Clinical Drug Investigation, Vol. 20, Iss. 1, 2000-07 ,pp. : 19-24

Adis International

Access to resources Recommend Favorite